842 related articles for article (PubMed ID: 24140245)
41. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
42. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
43. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
May M; Brookman-May S; Burger M; Gilfrich C; Fritsche HM; Rink M; Chun F; Fisch M; Roghmann F; Noldus J; Mayr R; Pycha A; Novotny V; Wirth M; Vallo S; Haferkamp A; Roigas J; Brisuda A; Stredele R; Volkmer B; Dechet C; Schnabel M; Denzinger S; Stief CG; Bastian PJ; Aziz A
Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
[TBL] [Abstract][Full Text] [Related]
44. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
[TBL] [Abstract][Full Text] [Related]
45. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
46. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
47. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
[TBL] [Abstract][Full Text] [Related]
48. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
Oh JJ; Kang MY; Jo JK; Lee HM; Byun SS; Lee SE; Lee S; Hong SK
Int J Urol; 2015 Dec; 22(12):1112-7. PubMed ID: 26290403
[TBL] [Abstract][Full Text] [Related]
49. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
50. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
51. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
52. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
53. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
54. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis.
Knoedler JJ; Boorjian SA; Kim SP; Weight CJ; Thapa P; Tarrell RF; Cheville JC; Frank I
J Urol; 2012 Oct; 188(4):1115-9. PubMed ID: 22901583
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
56. Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Xylinas E; Robinson BD; Kluth LA; Volkmer BG; Hautmann R; Küfer R; Zerbib M; Kwon E; Thompson RH; Boorjian SA; Shariat SF
Eur J Surg Oncol; 2014 Jan; 40(1):121-7. PubMed ID: 24140000
[TBL] [Abstract][Full Text] [Related]
57. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
Xylinas E; Rink M; Novara G; Green DA; Clozel T; Fritsche HM; Guillonneau B; Lotan Y; Kassouf W; Tilki D; Babjuk M; Karakiewicz PI; Montorsi F; Abdennabi J; Trinh QD; Svatek RS; Scherr DS; Zerbib M; Shariat SF
Ann Surg Oncol; 2013 Mar; 20(3):1027-34. PubMed ID: 23099729
[TBL] [Abstract][Full Text] [Related]
58. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
[TBL] [Abstract][Full Text] [Related]
59. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
60. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
